BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16262750)

  • 21. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prion hypothesis and the human prion diseases].
    Aguzzi A
    Berl Munch Tierarztl Wochenschr; 2002; 115(3-4):91-8. PubMed ID: 11938572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments.
    Hunter N; Houston F
    Dev Biol (Basel); 2002; 108():93-8. PubMed ID: 12220147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years.
    Martin M; Trouvin JH
    Transfus Clin Biol; 2013 Sep; 20(4):398-404. PubMed ID: 23910008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Confusion surrounding bovine spongiform encephalopathy (BSE) and the risk of new variant Creutzfeldt-Jakob disease].
    Hof G
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):501-2. PubMed ID: 11268917
    [No Abstract]   [Full Text] [Related]  

  • 26. [Creutzfeldt-Jakob disease: diagnosis, incidence, prevention and treatment].
    Croes EA; van Gool WA; Jansen GH; van Duijn CM
    Ned Tijdschr Geneeskd; 2002 Apr; 146(16):750-4. PubMed ID: 11998351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy.
    Axon AT; Beilenhoff U; Bramble MG; Ghosh S; Kruse A; McDonnell GE; Neumann C; Rey JF; Spencer K;
    Endoscopy; 2001 Dec; 33(12):1070-80. PubMed ID: 11740649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?].
    Paul J
    Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmissible spongiform encephalopathies.
    Sejvar JJ; Schonberger LB; Belay ED
    J Am Vet Med Assoc; 2008 Dec; 233(11):1705-12. PubMed ID: 19046027
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variant Creutzfeldt-Jakob disease and the acquired and transmissible spongiform encephalopathies.
    Beisel CE; Morens DM
    Clin Infect Dis; 2004 Mar; 38(5):697-704. PubMed ID: 14986255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [vCJD epidemiology in France].
    Brandel JP; Salomon D; Alpérovitch A
    Transfus Clin Biol; 2006 Nov; 13(5):304-6. PubMed ID: 17188544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW; Golker CF; Stadler P
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creutzfeldt-Jakob disease latest unknown in struggle to restore faith in blood supply.
    Vaughan P
    CMAJ; 1996 Sep; 155(5):565-8. PubMed ID: 8804263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bovine spongiform encephalopathy--a challenge for modern medicine].
    Kretzschmar H
    Internist (Berl); 1996 Jun; 37(6):658-60. PubMed ID: 8778074
    [No Abstract]   [Full Text] [Related]  

  • 37. Tissue safety in view of CJD and variant CJD.
    Pauli G
    Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [BSE, prions, vCJD and (not only) homologous transfusion].
    Köhler M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):43-7. PubMed ID: 12522730
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update.
    Lescoutra-Etchegaray N; Jaffré N; Sumian C; Durand V; Correia E; Mikol J; Luccantoni-Freire S; Culeux A; Deslys JP; Comoy EE
    Transfusion; 2015 Jun; 55(6):1231-41. PubMed ID: 25647476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.
    Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI
    J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.